M. Stimpel

489 total citations
40 papers, 351 citations indexed

About

M. Stimpel is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, M. Stimpel has authored 40 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 15 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Surgery. Recurrent topics in M. Stimpel's work include Blood Pressure and Hypertension Studies (12 papers), Hormonal Regulation and Hypertension (10 papers) and Adrenal and Paraganglionic Tumors (9 papers). M. Stimpel is often cited by papers focused on Blood Pressure and Hypertension Studies (12 papers), Hormonal Regulation and Hypertension (10 papers) and Adrenal and Paraganglionic Tumors (9 papers). M. Stimpel collaborates with scholars based in Germany, Switzerland and United States. M. Stimpel's co-authors include W. Vetter, Ludwig Neyses, William B. White, R Locher, H Groth, H. G. Weder, K Fehr, Birgit C. P. Koch, H. Vetter and R Streuli and has published in prestigious journals such as Biochemical Journal, Hypertension and British Journal of Pharmacology.

In The Last Decade

M. Stimpel

32 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Stimpel Germany 11 132 131 91 77 39 40 351
J.B. Ruidavets France 8 147 1.1× 127 1.0× 154 1.7× 53 0.7× 13 0.3× 16 391
Katsuya Obara Japan 6 67 0.5× 81 0.6× 36 0.4× 74 1.0× 10 0.3× 8 430
Yoshifumi Okura Japan 9 94 0.7× 67 0.5× 106 1.2× 117 1.5× 11 0.3× 22 336
Sheryl K. Cooney United States 10 85 0.6× 64 0.5× 54 0.6× 82 1.1× 9 0.2× 10 325
F. Liu United States 6 99 0.8× 110 0.8× 26 0.3× 114 1.5× 15 0.4× 8 344
S. Abdelhamid Germany 11 210 1.6× 60 0.5× 170 1.9× 67 0.9× 12 0.3× 33 411
Anu Kareinen Finland 10 134 1.0× 154 1.2× 129 1.4× 103 1.3× 9 0.2× 13 398
A. Asplund‐Carlson Sweden 8 219 1.7× 177 1.4× 146 1.6× 48 0.6× 6 0.2× 10 349
Masaaki Miyauchi Japan 11 121 0.9× 29 0.2× 54 0.6× 98 1.3× 12 0.3× 25 359
Zhi Luo China 10 42 0.3× 65 0.5× 94 1.0× 110 1.4× 38 1.0× 28 333

Countries citing papers authored by M. Stimpel

Since Specialization
Citations

This map shows the geographic impact of M. Stimpel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Stimpel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Stimpel more than expected).

Fields of papers citing papers by M. Stimpel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Stimpel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Stimpel. The network helps show where M. Stimpel may publish in the future.

Co-authorship network of co-authors of M. Stimpel

This figure shows the co-authorship network connecting the top 25 collaborators of M. Stimpel. A scholar is included among the top collaborators of M. Stimpel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Stimpel. M. Stimpel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stimpel, M.. (2008). Diagnostik des primären Aldosteronismus*. DMW - Deutsche Medizinische Wochenschrift. 117(23). 907–911.
2.
Stimpel, M., et al.. (2008). Diagnostische Bedeutung des Clonidin-Hemmtests bei Phäochromozytom-Verdacht. DMW - Deutsche Medizinische Wochenschrift. 113(4). 130–134.
3.
Stimpel, M., et al.. (2008). Diagnostik des Phäochromozytoms. DMW - Deutsche Medizinische Wochenschrift. 112(37). 1422–1425.
4.
Koch, Birgit C. P., Suzanne Oparil, & M. Stimpel. (1999). Co-administration of an ACE-inhibitor (moexipril) and hormonal replacement therapy in postmenopausal women. Journal of Human Hypertension. 13(5). 337–342. 10 indexed citations
5.
Agabiti‐Rosei, Enrico, et al.. (1999). Efficacy and tolerability of moexipril and nitrendipine in postmenopausal women with hypertension. European Journal of Clinical Pharmacology. 55(3). 185–189. 10 indexed citations
6.
Stimpel, M., Birgit C. P. Koch, & Michael A. Weber. (1998). Comparison between moexipril and atenolol in obese postmenopausal women with hypertension. Maturitas. 30(1). 69–77. 10 indexed citations
8.
Grohé, Christian, Stefan Kahlert, Martin van Eickels, et al.. (1997). Effects of moexiprilat on oestrogen‐stimulated cardiac fibroblast growth. British Journal of Pharmacology. 121(7). 1350–1354. 19 indexed citations
9.
Stimpel, M., et al.. (1997). Antihypertensive treatment with moexipril plus HCTZ vs metoprolol plus HCTZ in patients with mild-to-moderate hypertension. Journal of Human Hypertension. 11(2). 133–137. 6 indexed citations
10.
Persson, Bertil & M. Stimpel. (1996). Evaluation of the antihypertensive efficacy and tolerability of moexipril, a new ACE inhibitor, compared to hydrochlorothiazide in elderly patients. European Journal of Clinical Pharmacology. 50(4). 259–264. 10 indexed citations
11.
Persson, Bertil, et al.. (1995). Antihypertensive Effects of Moexipril, a New ACE Inhibitor, as Add-On Therapy to Nifedipine in Patients with Essential Hypertension. Journal of Cardiovascular Pharmacology. 26(1). 73–78. 7 indexed citations
12.
Stimpel, M., et al.. (1989). Therapeutic value of calcium antagonists in autonomous hyperaldosteronism. Journal of Molecular Medicine. 67(4). 248–252. 8 indexed citations
13.
Wambach, G., et al.. (1989). Impact of acute and chronic sodium loading on atrial natriuretic peptide and renin in man. Journal of Endocrinological Investigation. 12(10). 679–684. 5 indexed citations
14.
Stimpel, M., Katrin Ivens, G. Wambach, & W. Kaufmann. (1988). Are Calcium Antagonists Helpful in the Management of Primary Aldosteronism?. Journal of Cardiovascular Pharmacology. 12(Supplement 6). S131–S134. 9 indexed citations
16.
Stimpel, M., Ludwig Neyses, R Locher, M. Knorr, & W. Vetter. (1985). High density lipoproteins (HDL) - modulators of the calcium channel?. Hypertension. 3. 1 indexed citations
17.
Stimpel, M., et al.. (1985). The Spectrum of Renovascular Hypertension. Cardiology. 72(1). 1–9. 9 indexed citations
18.
Groth, H, et al.. (1985). [Nitrendipine, a new calcium antagonist, as basis therapy in essential hypertension].. PubMed. 74(19). 503–6. 2 indexed citations
19.
Stimpel, M., et al.. (1985). The scored tablet--a source of error in drug dosing?. PubMed. 3(1). S97–9. 7 indexed citations
20.
Neyses, Ludwig, et al.. (1984). Cholesterol and its oxidized derivatives modulate the calcium channel in human red blood cells.. Open Repository and Bibliography (University of Luxembourg). 2(3). S489–92. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026